We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Alliance to Promote Biomedical Education

By Biotechdaily staff writers
Posted on 29 May 2002
A partnership to form a new biomedical education program for clinical investigators and physician-scientists has been announced by Case Western Reserve University (CWRU, Cleveland, OH, USA) and The Cleveland Clinic Foundation (CCF). More...


In 2004, the new Cleveland Clinic College of Medicine of CWRU will enroll its first entering class, composed of up to 40 students from a national and international pool of applicants. The college will not duplicate the existing M.D. program of the CWRU School of Medicine. Fewer then 2% of US doctors are currently prepared to perform clinical research, according to the National Academy of Science's Institute of Medicine.

Doctors and scientists at the two institutions will work together to develop a pioneering curriculum that prepares students for careers as clinical investigators and doctor-scientists. Instruction will take place at both CCF and CWRU, as appropriate. CWRU will award degrees, which will note students' completion of the college's physician-investigator program. CCF and CWRU have agreed that research grants from the US National Institutes of Health to support work by CCF-based investigators should be awarded to and administered by the Cleveland Clinic College of Medicine. These wards will be included in the total research support for the CWRU School of Medicine, which is about US$174 million.

"This historic partnership will have a significant impact on medicine, research, and education,” said Floyd D. Loop, M.D., CEO of CCF. "Together, the Cleveland Clinic and Case Western Reserve University will raise the visibility and scale of these activities.”




Related Links:
Case Western Reserve University
Cleveland Clinic

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.